Read This Before Considering Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming US$0.60 Dividend
Bristol-Myers Squibb Company ( NYSE:BMY ) stock is about to trade ex-dividend in two days. The ex-dividend date is ...
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
FDA approves Bristol Myers' Opdivo for resectable non-small cell lung cancer, reducing recurrence risk by 42% and showing 70% 18-month event-free survival in patients.
Hosted on MSN1h
Bristol Myers Raises Profit Forecast on Drug Demand
(Bloomberg) -- Bristol Myers Squibb Co. raised its 2024 profit forecast as demand ... Bristol shares rose as much as 9.3% after US markets opened. The stock fell 12% this year through Thursday ...
Wall Street Breakfast Podcast: Bristol-Myers Wins FDA Nod For Novel Antipsychotic
Bristol-Myers wins FDA nod for novel antipsychotic. DirecTV, Dish close in on merger to form largest US pay-TV service: ...
Investor's Business Daily on MSN22h
Has Consumer Products Giant Bristol-Myers Squibb Kicked Into High Gear?
A Relative Strength Rating upgrade for Bristol Myers Squibb shows improving technical performance. Will it continue?
Hold Rating on Bristol-Myers Squibb Amid Market Challenges and Strategic Execution Risks
Leerink Partners analyst David Risinger has maintained their neutral stance on BMY stock, giving a Hold rating on September 26. David Risinger ...